Fulvestrant

Side effects and indications

Whenever possible, frequency information about the side effects was extracted from the labels. Aggregated frequency information for the drug and, if available, placebo is shown. To the right, you can click on shaded boxes to be taken to mentions of the side effect on the label. (In some cases, the side effect cannot be highlighted due to conversion problems.) Information about indications was extracted from the indications and usage sections of the labels.

Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5
Abdominal pain def postmarketing x x x x x
Anaemia def postmarketing x x x x x
Angioedema def postmarketing x x x
Anorexia def postmarketing x x x x x
Anxiety def postmarketing x x x x x
Arthritis def postmarketing x x x x x
Asthenia def postmarketing x x x x x
Back pain def postmarketing x x x x x
Chest pain def postmarketing x x x x x
Constipation def postmarketing x x x x x
Cough def postmarketing x x x x x
Diarrhoea def postmarketing x x x x x
Dizziness def postmarketing x x x x x
Dyspnoea def postmarketing x x x x x
Oedema def postmarketing x x x x x
Rash def postmarketing x x x x x
Body temperature increased def postmarketing x x x x x
Flushing def postmarketing x x x x
Headache def postmarketing x x x x x
Haemorrhage def postmarketing x x x x
Hypersensitivity def postmarketing x x x
Infection def postmarketing x x x x x
Inflammation def postmarketing x x x x x
Influenza def postmarketing x x x x x
Leukopenia def postmarketing x x x x
Nausea def postmarketing x x x x x
Pain def postmarketing x x x x x
Paraesthesia def postmarketing x x x x x
Pelvic pain def postmarketing x x x x x
Pharyngitis def postmarketing x x x x x
Pruritus def postmarketing x
Sweating def postmarketing x x x x x
Urinary tract infection def postmarketing x x x x x
Urticaria def postmarketing x x x
Vasodilation def postmarketing x x x x x
Vertigo def postmarketing x x x x
Vomiting def postmarketing x x x x x
Oedema peripheral def postmarketing x x x x x
Bleeding vaginal def postmarketing x x x x
Injection site reaction def postmarketing x x x x x
Bone pain def postmarketing x x x x x
Injection site pain postmarketing x x x x x
Myalgia def postmarketing x x x x
Digestion impaired postmarketing x
Hepatic enzyme increased postmarketing x x
Cough increased postmarketing x x x x
Hot flush def postmarketing x x x x x
Insomnia def postmarketing x x x x x
Arthralgia def x
Fatigue def x
Musculoskeletal pain def x
Pain in extremity def x
Gastrointestinal symptom NOS x x x x
Indication Labels
Breast cancer def x x x x x
Breast cancer stage IV def x x x x x
Disease progression def x x x x x
Neoplasm malignant def x x x x x

Information

More information: STITCH, PubChem and possibly Wikipedia or Medpedia

ATC Code: L02BA03

Legend

Color scheme: standard – alternative

100%    
75%    
50%    
10%    
frequent (1% to 100%)    
infrequent (0.1% to 1%)    
rare (<0.1%)    
postmarketing    
0%    
no frequency information    
not found on label    

Labels

Labels were obtained from different sources and potentially contain different sets of side effects. If you click on the label name, a HTML version of the label will be shown with proteins, chemicals and side efffects highlighted using Reflect.

  1. FULVESTRANT / FASLODEX : 43 side effects (Health Canada)
  2. fulvestrant / FASLODEX : 42 side effects (FDA CDER)
  3. fulvestrant / FASLODEX : 43 side effects (FDA CDER)
  4. FULVESTRANT / FASLODEX : 46 side effects (Drugs@FDA)
  5. FULVESTRANT : 50 side effects (FDA XML label)